Publikationen in Zusammenarbeit mit Forschern von Hospital Carlos III (33)

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

  3. Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain

    AIDS Research and Human Retroviruses, Vol. 30, Núm. 9, pp. 856-862

  4. Very late HCV relapse following triple therapy for hepatitis C

    Antiviral Therapy

  5. X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain

    AIDS, Vol. 28, Núm. 11, pp. 1603-1609

2013

  1. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B

    AIDS, Vol. 27, Núm. 14, pp. 2219-2224

  2. Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002

  3. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

  4. Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir

    Antiviral Therapy, Vol. 18, Núm. 5, pp. 709-715

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  2. Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms

    Clinical Infectious Diseases, Vol. 55, Núm. 1

  3. Diarrhoeagenic Escherichia coli pathotypes in travellers attending a tropical medicine unit in a Spanish hospital

    Journal of Medical Microbiology

  4. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

    Virology Journal, Vol. 9, Núm. 1

2011

  1. Drug resistance mutations in patients infected with HIV-2 living in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 7, pp. 1484-1488

  2. HTLV infection among foreign pregnant women living in Spain

    Journal of Clinical Virology, Vol. 52, Núm. 2, pp. 119-122

  3. Variabilidad en la determinación del tropismo viral del VIH utilizando diferentes algoritmos genotípicos de interpretación en pacientes VIH-1 infectados con subtipos B versus no-B

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 1, pp. 4-8

2010

  1. Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey

    AIDS Research and Human Retroviruses, Vol. 26, Núm. 8, pp. 861-864

  2. Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 65, Núm. 12, pp. 2502-2504

2009

  1. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 5, pp. 1006-1010

  2. Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain

    AIDS Research and Human Retroviruses, Vol. 25, Núm. 6, pp. 551-554